Herbas VPB

Print
EN | LT
LT - TREATMENT OF CANCER WITH TG02
EN - TREATMENT OF CANCER WITH TG02

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 45/06 (2013.01)
A61K 31/519 (2006.01)
A61K 41/00 (2020.01)
A61K 31/44 (2013.01)
A61P 35/00 (2006.01)
A61K 31/454 (2013.01)
A61P 35/02 (2006.01)
A61K 31/495 (2013.01)
A61K 31/535 (2006.01)
A61K 31/519 (2013.01)
A61K 45/06 (2006.01)
A61K 31/69 (2013.01)
A61K 33/24 (2019.01)
A61K 31/704 (2013.01)
A61P 35/00 (2018.01)
A61K 31/704 (2006.01)
A61P 35/02 (2018.01)
A61K 31/69 (2006.01)
A61K 33/243 (2019.01)
A61K 31/495 (2006.01)
A61N2005/1098 (2013.01)
A61K 31/454 (2006.01)
A61K 31/44 (2006.01)
C07D 498/06 (2006.01)
European patent
(11) Number of the document 3432888
(13) Kind of document T
(96) European patent application number 17771215.5
Date of filing the European patent application 2017-03-24
(97) Date of publication of the European application 2019-01-30
(45) Date of publication and mention of the grant of the patent 2022-10-05
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2017/023965
Date 2017-03-24
PCT application publication
(87) Number WO 2017/165732
Date 2017-09-28
Priority applications
(30) Number Date Country code
201662312712 P 2016-03-24 US
201662423468 P 2016-11-17 US
Inventors
(72)
ESTOK, Thomas M. , US
WEBER, Eckard , US
PARROTT, Tracy , US
Grantee
(73) Cothera Bioscience, Inc. , Conyers Trust Company (Caymen) Limited Cricket Square, Hutchins Drive PO Box 2681, Grand Cayman, KY1-1111, KY
Title
(54) TREATMENT OF CANCER WITH TG02
  TREATMENT OF CANCER WITH TG02